航天晨光(600501.SH)完成轉讓華業公司55%股權
格隆匯11月26日丨航天晨光(600501.SH)公佈,公司通過北京產權交易所以公開掛牌方式轉讓所持有的南京華業聯合投資有限公司(以下簡稱華業公司)55%股權。本次交易的最終價格為人民幣3301.83萬元。
截至2019年11月25日,亞東建設已支付全部股權受讓款共計3301.83萬元,北京產權交易所已出具國有資產交易憑證。
本次轉讓華業公司股權是基於公司轉型升級及戰略發展需要,有利於集中優勢資源,聚焦主業發展。通過本次股權掛牌轉讓,公司將獲得投資收益約2800萬元(具體數據請以年度審計報告確認的金額為準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.